Noven Financial Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Noven Financial Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-6,090	Closed	-$404K	–	47
2015 Q3	$404K	Buy	6,090 +775	+15%	+$60.3K	0.33%	28
2015 Q2	$416K	Buy	5,315 +163	+3%	+$12.7K	0.3%	26
2015 Q1	$394K	Sell	5,152 -132	-2%	-$9.7K	0.28%	25
2014 Q4	$352K	Buy	+5,284	New	+$352K	0.26%	30
2014 Q3	–	Sell	-19,939	Closed	-$1.22M	–	39
2014 Q2	$1.22M	Sell	19,939 -702	-3%	-$40.7K	0.88%	23
2014 Q1	$1.17M	Buy	+20,641	New	+$1.17M	0.9%	21

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Noven Financial Group's PJP Position: Q4 2015 in Review

Noven Financial Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2015, closing a stake of 6,090 shares — an estimated $404K sold.

Noven Financial Group first reported a position in PJP in Q1 2014 and held it in 6 quarters. The position peaked at $1.22M in Q2 2014. 112 funds tracked by Wall St. Rank hold PJP as of Q4 2015.

Noven Financial Group reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Noven Financial Group sold 6,090 Invesco Pharmaceuticals ETF shares in Q4 2015, an estimated $404K.
Noven Financial Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2014 and held it in 6 quarters.
Noven Financial Group's Invesco Pharmaceuticals ETF position peaked at $1.22M in Q2 2014.
112 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2015.

Based on Noven Financial Group's 13F filing for Q4 2015, filed 11 Feb 2016.